Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05677191
Other study ID # Orthopedic
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date January 1, 2023
Est. completion date December 31, 2024

Study information

Verified date January 2023
Source Cairo University
Contact Marcos Ha Morris
Phone 1287076751
Email marcos.hanna.morris@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Proximal femoral nail [PFNA] versus dual mobility arthroplasty in treatment of unstable trochanteric fractures


Description:

compare clinial outcome between two different procdures either using pfna or arthroplasty in the treatment of unstable trochaneric fractures


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date December 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: - patients with trochanteric unstable fractures. - age 60 or above - recent fracture time within 2 weeks time period - trochanteric starting point in pfna - patients medical condition is stable Exclusion Criteria: - stable trochanteric fractures - delayed or neglected fractures - unstable patients medical conditions - pirformis fossa starting point in pfna

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Proximal Femoral Nail
open reduction
Combination Product:
Dual Mobility Arthroplasty
Hip Arthroplasty Surgery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Hip score compare between hip score in first group of pfna versus hip score in second group of THA Through study completion, an average of 1 year"
Primary Operation time compartive operative time between first group of pfna versus second group of THA During surgery
See also
  Status Clinical Trial Phase
Withdrawn NCT00741182 - Effect of PTH(1-34) Treatment on Fracture Healing in Vivo Phase 2
Completed NCT02294747 - Trochanteric Hip Fractures (AO A2) SHS With or Without Trochanteric Stabilizing Plate - Rct Using RSA N/A
Completed NCT00873548 - Treatment of Unstable Trochanteric Fractures With the Proximal Femoral Nail - Antirotation (PFNA)-Asia
Enrolling by invitation NCT05587244 - G7 Freedom Constrained Vivacit-E Liners N/A
Recruiting NCT02672696 - Interest of Navigation for the Treatment of Pertrochanteric Fractures With the Gamma 3 Nail N/A
Enrolling by invitation NCT05548972 - G7 Dual Mobility With Vivacit-E or Longevity PMCF N/A
Not yet recruiting NCT03531983 - Results of Gamma Nail in Trochentric Fractures of the Adults
Recruiting NCT05362864 - ZNN Bactiguard Cephalomedullary Nails PMCF Study
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Active, not recruiting NCT05144191 - Insignia™ Hip Stem Outcomes Study N/A
Recruiting NCT05781815 - Treatment Of Unstable Trochanteric Fracture: A Comparative Study Between DHS And DHS With Trochanteric Stabilization Plate N/A
Active, not recruiting NCT03266874 - G7 BiSpherical Acetabular Shell PMCF Study